| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.04B | +64.0% |
| R&D Expense | $257.6M | +1.6% |
| SG&A Expense | $253.7M | +9.9% |
| Operating Income | $42.6M | +124.7% |
| Income Tax | $728K | +293.5% |
| Net Income | $53.6M | +141.7% |
| EPS (Basic) | $0.56 | +138.9% |
| EPS (Diluted) | $0.45 | +131.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $652.4M | -17.3% |
| Total Assets | $2.97B | +25.7% |
| Total Liabilities | $2.18B | +25.5% |
| Stockholders' Equity | $798.8M | +26.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$147.7M | -179.3% |
| Capital Expenditures | $347K | -58.5% |
| Investing Cash Flow | -$177.2M | +25.5% |
| Financing Cash Flow | $405.6M | -27.5% |
| Free Cash Flow | -$148.1M | -179.8% |